Abstract
Background: Conflicting data exist on the effects of GH replacement therapy (GHRT) on thyroid function and thyroid volume (TV) in GH-deficient (GHD) patients. Aim: The aim of this study was to assess the effects of GHRT on thyroid function and TV in adults with congenital lifetime isolated GHD (IGHD). Subjects and methods: We studied 20 GH-naïve adults with IGHD due to a homozygous mutation of the GHRH-receptor gene at baseline, after 6-month depot-GH replacement therapy (pGH), and 6-month washout (6mo). Total T3, free T4 (FT4), reverse T3 (rT3), TSH, IGF-I, SHBG, and TV were measured; body surface area-corrected TV (CTV) was calculated. Results: IGF-I and T3 increased pGH. T3 levels remained elevated at 6mo. GHRT did not significantly change FT4, rT3, TSH, and SHBG. TV and CTV increased pGH and remained elevated at 6mo. Conclusions: GHRT in IGHD adults caused an increase in serum T3 levels and TV, suggesting an important role of the GH-IGF-I axis in thyroid function.
Similar content being viewed by others
References
Losa M, Scavini M, Gatti E, et al. Long-Term Effects of Growth Hormone Replacement Therapy on Thyroid Function in Adults with Growth Hormone Deficiency. Thyroid 2008, 18: 1249–54.
Agha A, Walker D, Perry L, et al. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) 2007, 66: 72–7.
Wyatt DT, Gesundheit N, Sherman B. Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation. J Clin Endocrinol Metab 1998, 83: 3493–7.
Porretti S, Giavoli C, Ronchi C, et al. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab 2002, 87: 2042–5.
Jørgensen JO, Møller J, Laursen T, Orskov H, Christiansen JS, Weeke J. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf) 1994, 41: 609–14.
Seminara S, Stagi S, Candura L, et al. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?. Horm Metab Res 2005, 37: 751–6.
Porter BA, Refetoff S, Rosenfeld RL, De Groat LJ, Lang US, Stark O. Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy. Pediatrics 1973, 51: 668–74.
Amato G, Izzo G, Salzano I, Bellastella A. Recombinant human growth hormone treatment at low doses does not significantly change thyroid function in growth hormone deficient adults. J Endocrinol Invest 1996, 19: 563–6.
Beere HM, Soden J, Tomlinson S, Bidey SP. Insulin-like growth factor-I production and action in porcine thyroid follicular cells in monolayer: regulation by transforming growth factor-beta. J Endocrinol 1991, 130: 3–9.
Maciel RB, Moses AC, Villone G, Tramontano D, Ingbar SH. Demonstration of the production and physiological role of insulin-like growth factor II in rat thyroid follicular cells in culture. J Clin Invest 1998, 82: 1546–53.
Eggo MC, Bachrach LK, Burrow GN. Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function. Growth Factors 1990, 2: 99–109.
Tramontano D, Cushing GW, Moses AC, Ingbar SH. Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves’-IgG. Endocrinology 1986, 119: 940–2.
Misaki T, Maciel RM, Tramontano D, Moses AC, Lombardi A, Ingbar SH. Supranormal stimulation of deoxyribonucleic acid synthesis in FRTL5 cells by serum from patients with untreated acromegaly. J Clin Endocrinol Metab 1988, 66: 1227–32.
Cannavò S, Squadrito S, Finocchiaro MD, et al. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up. Horm Metab Res 2000, 32: 190–5.
Cheung NW, Boyages SC. The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol 1997, 46: 545–9.
Cheung NW, Lou JC, Boyages SC. Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism. J Clin Endocrinol Metab 1996, 81: 1179–83.
Salvatori R, Hayashida CY, Aguiar-Oliveira MH, et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab 1999, 84: 917–23.
Alcântara MR, Salvatori R, Alcântara PR, et al. Thyroid morphology and function in adults with untreated isolated growth hormone deficiency. J Clin Endocrinol Metab 2006, 91: 860–4.
Cook DM, Biller BM, Vance ML, et al. The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (Nutropin Depot) in GH deficient adults. J Clin Endocrinol Metab 2002, 87: 4508–14.
Hoffman AR, Biller BM, Cook D, et al; Genentech Adult Growth Hormone Deficiency Study Group. Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab 2005, 90: 6431–40.
Du Bois D, Du Bois EF. A formula to estimate the approximate surface area IF height and weight be known. Arch Intern Med 1916, 17: 863–71.
Oliveira JL, Aguiar-Oliveira MH, D’Oliveira A Jr, et al. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults. J Clin Endocrinol Metab 2007, 92: 4664–70.
de Paula FJ, Góis-Júnior MB, Aguiar-Oliveira MH, et al. Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene. Clin Endocrinol (Oxf) 2009, 70: 35–40.
Barbosa JA, Salvatori R, Oliveira CR, et al. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency Psychoneuroendocrinology 2009, 34: 894–900.
Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 2006, 116: 2571–9.
Binnerts A, Swart GR, Wilson JH, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 1992, 37: 79–87.
Municchi G, Malozowski S, Nisula BC, Cristiano A, Rose SR. Nocturnal thyrotropin surge in growth hormone-deficient children. J Pediatr 1992, 121: 214–20.
Jørgensen JO, Møller J, Skakkebaek NE, Weeke J, Christiansen JS. Thyroid function during growth hormone therapy. Horm Res 1992, 38: 63–7.
Klinger B, Ionesco A, Anin S, Laron Z. Effects of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects. Acta Endocrinol (Copenh) 1992, 127: 515–9.
Hussain MA, Schmitz O, Jorgensen JO, et al. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Eur J Endocrinol 1996, 134: 563–7.
Payne KL, Loidl NM, Lim CF, Topliss DJ, Stockigt JR, Barlow JW. Modulation of T3-induced sex hormone-binding globulin secretion by human hepatoblastoma cells. Eur J Endocrinol 1997, 137: 415–20.
Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Clin Endocrinol (Oxf) 2003, 58: 601–11.
Brenta G, Bedecarras P, Schnitman M, et al. Characterization of sex hormone-binding globulin isoforms in hypothyroid women. Thyroid 2002, 12: 101–5.
Takahashi S, Conti M, Van Wyk JJ. Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s). Endocrinology 1990, 126: 736–45.
Gómez JM, Maravall FJ, Gómez N, Gumà A, Soler J. Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected. Clin Endocrinol (Oxf) 2000, 53: 629–34.
Kaplan SA, Cohen P. The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 2007, 92: 4529–35.
Alba M, Fintini D, Salvatori R. Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice. Growth Horm IGF Res 2005, 15: 275–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leite, N.T.F., Salvatori, R., Alcântara, M.R.S. et al. Effects of depot growth hormone replacement on thyroid function and volume in adults with congenital isolated growth hormone deficiency. J Endocrinol Invest 35, 265–268 (2012). https://doi.org/10.3275/7608
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/7608